Completed NCT05113953
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Phoenix Eating disorders Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Eating disorders Completed NCT05279313
This study is looking at whether Centanafadine Hydrochloride can help people with Attention Deficit/Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
Multiple locations, including Dothan ADHD Drug From 4 Years to 18 Years
Countries United States, Canada
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Withdrawn NCT02476331
This study exists to compare options and see whether the medication Cognitive offers something meaningfully different. Researchers are trying to understand whether the medication Cognitive can improve attention, thinking, or day-to-day functioning.
In Calgary Bipolarity Behavioral From 18 Years to 65 Years
Countries Canada
Sponsor University of Calgary
Condition Bipolarity Completed NCT02478827
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Calgary Schizophrenia Behavioral From 18 Years to 65 Years
Countries Canada
Sponsor University of Calgary
Condition Schizophrenia Completed NCT06706739
This summary needs review. Please check the official study record and contact the research team for details.
In Fuzhou Depression Other Over 60 Years
Countries China
Sponsor Fujian Medical University
Condition Depression Completed NCT00956605
This summary needs review. Please check the official study record and contact the research team for details.
In Boston ADHD Behavioral From 10 Years to 15 Years
Countries United States
Sponsor Tufts Medical Center
Condition ADHD Completed NCT03365362
This summary needs review. Please check the official study record and contact the research team for details.
In The Bronx Addiction Drug Over 18 Years
Countries United States
Sponsor Albert Einstein College of Medicine
Condition Addiction Completed NCT02357173
This summary needs review. Please check the official study record and contact the research team for details.
In Charleston Addiction Other Over 18 Years
Countries United States
Sponsor Medical University of South Carolina
Condition Addiction Completed NCT01724476
This summary needs review. Please check the official study record and contact the research team for details.
In Addis Ababa Schizophrenia Drug From 18 Years to 65 Years
Countries Ethiopia
Sponsor Massachusetts General Hospital
Condition Schizophrenia Completed NCT05800860
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Pilsen Depression Drug From 18 Years to 64 Years
Countries Czechia, Germany, Ireland, ...
Sponsor GH Research Ireland Limited
Condition Depression Completed NCT00984698
This summary needs review. Please check the official study record and contact the research team for details.
In Tucson PTSD, Depression Behavioral From 18 Years to 65 Years
Countries United States
Sponsor University of Arizona
Condition PTSD, Depression Completed NCT05273567
This summary needs review. Please check the official study record and contact the research team for details.
In New York Addiction Drug From 18 Years to 65 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition Addiction